The P{EP}RhoGEF64CEP3035 insertion present in the progenitor line is also still present.
Amino acid replacement: Q581term.
C4766633T
Q582term | RhoGEF64C-PA; Q582term | RhoGEF64C-PB
Q581term
The point mutation was introduced onto a chromosome containing the P{EP}EP3035 insertion.
Site of nucleic acid difference in mutant inferred by FlyBase based on reported amino acid change.
Expression of Gef64C1 under the control of Scer\GAL4elav.PLu (using the P{EP}Gef64CEP3035 insertion present on the Gef64C1 chromosome) does not result in a gain of function defective axon guidance phenotype.
Embryos that are both maternally and zygotically mutant for RhoGEF204291 and are also heterozygous or homozygous for Gef64C1 show a mild increase in the frequency of spiracle defects compared to embryos that are both maternally and zygotically mutant for RhoGEF204291 in a Gef64C+ background.